Immune-checkpoint inhibition in stage III unresectable NSCLC: Challenges and opportunities in the post-PACIFIC era-Reference-Cited by-同舟云学术

Immune-checkpoint inhibition in stage III unresectable NSCLC: Challenges and opportunities in the post-PACIFIC era

Published:2021-07 Issue: Volume:157 Page:85-91
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Passiglia Francesco,Leone Gianmarco^ORCID,Olmetto Emanuela,Delcuratolo Marco Donatello^ORCID,Tabbò Fabrizio^ORCID,Reale Maria Lucia^ORCID,Bertaglia Valentina,Consito Lorena,Bironzo Paolo^ORCID,Capelletto Enrica,Novello Silvia^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference40 articles.

1. Trends in stage distribution for patients with non-small cell lung cancer: a National Cancer Database survey;Morgensztern;J. Thorac. Oncol.,2010

2. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Postmus;Ann. Oncol.,2017

3. Individualized accelerated isotoxic concurrent chemo-radiotherapy for stage III non-small cell lung cancer: 5-year results of a prospective study;De Ruysscher;Radiother. Oncol.,2019

4. Long-term results of NRG oncology RTOG 0617: standard- versus high-dose chemoradiotherapy with or without cetuximab for unresectable stage III non-small-cell lung cancer;Bradley;Clin. Oncol.,2020

5. Elderly patients with stage III NSCLC survive longer when chemotherapy is added to radiotherapy-fortune favours the bold;Arulananda;Transl. Lung Cancer Res.,2018

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The 8th Edition TNM Stage Reclassification of T4 Non-Small Cell Lung Cancer: A Granular Examination of Short and Long-Term Outcomes;Clinical Lung Cancer;2023-09

2. Immunotherapy in Elderly Patients Affected by Non-Small Cell Lung Cancer: A Narrative Review;Journal of Clinical Medicine;2023-02-24

3. Unmet needs in the management of unresectable stage III non-small cell lung cancer: a review after the ‘radio talk’ webinars;Expert Review of Anticancer Therapy;2022-04-25

4. Radiotherapy Patterns of Care for Locally-advanced Non-small Cell Lung Cancer in the Pre- and Post-durvalumab Era: A Region-wide Survey in a Japanese Prefecture;Journal of Radiation Research;2021-12-30

5. A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer;Frontiers in Oncology;2021-09-28